Table 2.

pCa-force results (pCa50, h) for each individual patient sample

Pat.-ID	pCa50	h	n	SL (μm)
ctrl#1	6.21 ± 0.02	2.69 ± 0.34	6	2.1
ctrl#2	6.23 ± 0.07	2.76 ± 0.42	6	2.5
ctrl#3	6.14 ± 0.02	3.18 ± 0.41	6	2.1
ctrl#4	5.91 ± 0.02	1.65 ± 0.13	6	2.4
ctrl#5	5.40 ± 0.02	1.78 ± 0.09	5	2.3
PnC#1	6.01 ± 0.01	2.42 ± 0.16	6	2.3
PnC#2	6.19 ± 0.03	2.33 ± 0.34	6	2.4
PnC#3	6.13 ± 0.03	2.23 ± 0.45	6	2.4
PnC#4	6.07 ± 0.02	2.62 ± 0.22	6	2.7
PnC#5	5.98 ± 0.03	2.37 ± 0.27	6	2.2
PnC#6	6.11 ± 0.02	2.08 ± 0.21	6	2.2
PnC#7	6.03 ± 0.02	2.32 ± 0.21	6	2.1
PnC#8	5.83 ± 0.02	1.87 ± 0.01	6	2.3
PC#1	6.06 ± 0.02	2.32 ± 0.25	6	2.1
PC#2	6.16 ± 0.03	2.35 ± 0.32	6	2.2
PC#3	6.23 ± 0.03	2.60 ± 0.34	5	2.2
PC#4	6.13 ± 0.02	2.06 ± 0.19	7	2.5
PC#5	6.10 ± 0.03	1.97 ± 0.21	6	2.4
PC#6	5.48 ± 0.02§	1.88 ± 0.09	4	2.3

^§Significant outlier (P < 0.05).

SL: sarcomere length; n: number of recordings from different fibre bundles of each patient sample.